3rd Quarter - Report

HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for PHARMATHENE

Period 3rd Quarter 2011 Filed Oct 20, 2011 Signed by Christine M. Warnke, Senior Governmental Affairs Advisor

Official filing
Firm
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Client
PHARMATHENE
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR 2402, Pandemic All-Hazard Preparedness Reauthorization Act.

LobbyistCovered position, as disclosed
CHRISTINE M WARNKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2402 (112th)

Budget/Appropriations BUD

FY 2012 Labor, HHS Appropriations, S 1599FY 2012 Continuing Resolution, HR 2608, HR 2017.

LobbyistCovered position, as disclosed
CHRISTINE M WARNKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2017 (112th), H.R. 2608 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.